NHS National Framework for low molecular weight heparin products and fondaparinux

Concepts

• pharmaceutical products
• period of framework
• runcorn
• nhs national framework
• low molecular weight heparin products
• fondaparinux
• authority's discretion
• september
• august
• phr

Location

Description

NHS National Framework for low molecular weight heparin products and fondaparinux Offer reference number: CM/PHR/22/5687 Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

Document No. 04a - Quality Assurance Process - CM-PHR-22-5687 Document No. 04a - Quality Assurance Process - CM-PHR-22-5687.pdf Document No. 05a - Selectt Offer File CM_PHR_22_5687_01 Document No. 05a - Selectt Offer File CM_PHR_22_5687_01.xml Document No. 05b - Tender Product Listing and Usage Document No. 05b - Tender Product Listing and Usage.xlsx Document No. 01 - Invitation to offer covering letter - CM-PHR-22-5687 Document No. 01 - Invitation to offer covering letter - CM-PHR-22-5687.docx Document No. 03 - Framework Agreement and Terms and Conditions - CM-PHR-22-5687 Document No. 03 - Framework Agreement and Terms and Conditions - CM-PHR-22-5687.docx Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements - CM-PHR-22-5687 Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements - CM-PHR-22-5687.pdf Document No. 05 - Selectt offer schedule instructions - CM-PHR-22-5687 Document No. 05 - Selectt offer schedule instructions - CM-PHR-22-5687.doc Document No. 02 - Terms of offer - CM-PHR-22-5687 Document No. 02 - Terms of offer - CM-PHR-22-5687.docx Document No. 06 - Form of offer - CM-PHR-22-5687 Document No. 06 - Form of offer - CM-PHR-22-5687.doc Document No. 07a - Quality control technical sheet - CM-PHR-22-5687 Document No. 07a - Quality control technical sheet - CM-PHR-22-5687.pdf Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022 Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022.pdf Document No. 08 - Confidential information schedule - CM-PHR-22-5687 Document No. 08 - Confidential information schedule - CM-PHR-22-5687.xls Document No. 09 - Participating Authorities - CM-PHR-22-5687 Document No. 09 - Participating Authorities - CM-PHR-22-5687.xls